A Randomized controlled trial of modified Respiratory Guixinggong in delaying the progression of Pulmonary dysfunction in patients with mild to moderate COPD

Affiliated Hospital of Chengdu University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. patients aged 45-75 years with mild to moderate COPD in stable stage;
•2. meet the diagnostic criteria: FEV1/FVC < 70% after using bronchodilator, and FEV1 >=50% after using bronchodilator, with a history of respiratory symptoms and / or risk factors exposure;
•3. one month or more after acute attack treatment;
•4. did not participate in other traditional exercise before being selected;
•5. voluntarily participated in this study with informed consent and signed informed consent form;
•6. those with clear consciousness and stable cardiopulmonary function.

•1. patients with chronic cough and wheezing caused by tuberculosis, fungus, tumor, irritant gas, allergy and other factors; and patients diagnosed as bronchial asthma, bronchiectasis, lung cancer, congestive heart failure, bronchiolitis obliterans, diffuse panbronchiolitis, bronchial keratosis, etc.;
•2. patients with cardiovascular, urinary, digestive, blood, endocrine and other serious primary diseases and inability to cooperate with spirit, intelligence or even thinking;
•3. pregnant or lactating women;
•4. patients who are participating in other clinical trials;
•5. researchers believe that other reasons are not suitable for clinical trials.

发起方

Affiliated Hospital of Chengdu University of traditional Chinese Medicine